Skip to main content

Table 3 Summary of adverse events

From: A randomized, double-blind, placebo-controlled study of the effect of ezetimibe on glucose metabolism in subjects with type 2 diabetes mellitus and hypercholesterolemia

 

Ezetimibe

Placebo

 

n (%)

n (%)

Subjects in population

75

77

With ≥1 adverse events

37 (49.3)

50 (64.9)

With drug-related adverse events

3 (4)

1 (1.3)

With serious adverse events

2 (2.7)

5 (6.5)

Discontinued due to an adverse event

1 (1.3)

1 (1.3)

Discontinued due to a serious adverse event

0 (0)

1 (1.3)